Actress and content creator Chhavi Mittal, a breast cancer survivor, has shared a candid health update about undergoing surgery to remove a large uterine fibroid. The growth, she explained, developed as a side effect of long-term medication prescribed after her cancer treatment. In her recent communication, she expressed the frustration and emotional weight of facing yet another medical procedure years after being declared cancer-free.
A Continuation of the Cancer Journey
Mittal was diagnosed with breast cancer in 2022 and underwent a major surgery lasting several hours. She has often described the date of that operation as a form of “new birth,” marking the start of life as a survivor. While the primary treatment addressed the cancer, she has remained on long-term hormone therapy, including the drug Tamoxifen, which is commonly prescribed to reduce the risk of recurrence in certain types of breast cancer.
In her update, Mittal noted that side effects of such medications are not always limited to the period of active treatment. Some effects continue or emerge later, creating what she has called a “butterfly effect” in which one medical intervention leads to further complications requiring additional care.
The Fibroid and Its Rapid Growth
According to Mittal, she had a small uterine fibroid measuring roughly 1.25 centimetres that had remained largely stable for about two decades. After she began taking Tamoxifen, the fibroid grew significantly and reached approximately 7.2 centimetres. She stated that research supports a connection between the medication and accelerated fibroid growth in some patients.
The enlarged fibroid began causing substantial problems. Mittal described heavy menstrual bleeding that required frequent changes of sanitary products, severe pain, the passage of clots, pressure on the bladder, and related gut and intestinal discomfort. Everyday activities became difficult, and the symptoms disrupted her routine in ways she had not experienced before.
Deciding on Surgery
Faced with a fibroid that continued to grow and increasingly affected her quality of life, Mittal decided to proceed with surgical removal. She framed the choice as necessary rather than optional, noting that leaving the growth untreated would likely lead to further deterioration. In her message, she reflected on the emotional complexity of packing for another hospital stay and confronting the reality that cancer’s aftermath can involve ongoing medical interventions.
She has previously spoken about other side effects linked to hormone therapy, including mood changes, reduced bone density, and episodes of extreme menstrual pain. The fibroid surgery represents one more chapter in managing these longer-term consequences.
The Emotional Tone of the Update
Mittal’s communication carried a tone of weary acceptance mixed with determination. Phrases reflecting frustration with the continued physical challenges appeared alongside her characteristic resolve. She has long used her platform to discuss the less visible aspects of survivorship—the non-linear nature of healing, the persistence of side effects, and the mental load of repeated medical procedures.
By sharing the details of the fibroid’s growth and the decision to operate, she continues a pattern of openness that began during her initial cancer treatment. She has consistently emphasised that recovery does not end when the primary disease is controlled and that survivors often navigate a series of secondary health issues.
Raising Awareness About Treatment Side Effects
Mittal’s update draws attention to an important but sometimes under-discussed aspect of cancer care: the long-term impact of hormone therapies such as Tamoxifen. While these medications play a critical role in reducing recurrence risk, they can influence hormonal balance, uterine tissue, bone health and menstrual patterns. Fibroid growth is one documented possibility among other potential effects.
Her willingness to speak publicly helps normalise conversations about these challenges. Many survivors experience similar secondary issues yet may feel isolated if the focus remains solely on the original cancer diagnosis. By detailing both the medical facts and the emotional experience, Mittal contributes to a broader understanding of what life after cancer can involve.
Looking Ahead
Surgery to remove a sizable fibroid is a significant procedure, and recovery typically requires time and careful post-operative care. Mittal has indicated an awareness that healing from this operation will itself demand patience. Throughout her cancer journey she has stressed the value of taking life one day at a time, recognising that strength fluctuates and that difficult periods are part of the process.
Her latest health update underscores that survivorship is rarely a straight line. The same determination that carried her through breast cancer treatment is now being applied to managing the consequences of the therapies that helped save her life. In sharing her experience with characteristic honesty, Chhavi Mittal continues to offer visibility to the complex, ongoing realities faced by many cancer survivors.
Read more – toolsbyalaikas.com
